Cargando…

Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial

INTRODUCTION: The retina and brain exhibit similar pathologies in patients diagnosed with neurodegenerative diseases. The ability to access the retina through imaging techniques opens the possibility for non‐invasive evaluation of Alzheimer's disease (AD) pathology. While retinal amyloid deposi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngolab, Jennifer, Donohue, Michael, Belsha, Alison, Salazar, Jennifer, Cohen, Paula, Jaiswal, Sandhya, Tan, Veasna, Gessert, Devon, Korouri, Shaina, Aggarwal, Neelum T., Alber, Jessica, Johnson, Ken, Jicha, Gregory, van Dyck, Christopher, Lah, James, Salloway, Stephen, Sperling, Reisa A., Aisen, Paul S., Rafii, Michael S., Rissman, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Retinal Imaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369843/ https://www.ncbi.nlm.nih.gov/pubmed/34430703 http://dx.doi.org/10.1002/dad2.12199

Ejemplares similares

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
por: den Haan, Jurre, et al.
Publicado: (2019)

Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline
por: Dumitrascu, Oana M., et al.
Publicado: (2020)

Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials
por: Langford, O., et al.
Publicado: (2020)

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
por: den Haan, Jurre, et al.
Publicado: (2019)

Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort study
por: Sato, Kenichiro, et al.
Publicado: (2021)

The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults
por: Insel, Philip S., et al.
Publicado: (2020)

Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2
por: Ngolab, Jennifer, et al.
Publicado: (2021)

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial
por: van Dyck, Christopher H., et al.
Publicado: (2019)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview
por: Aisen, P.S., et al.
Publicado: (2020)

Impact of sex and APOE ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults
por: Petersen, Kellen K., et al.
Publicado: (2022)

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
por: Insel, Philip S., et al.
Publicado: (2017)

Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study
por: Marshall, Gad A., et al.
Publicado: (2020)

The AHEAD 3–45 Study: Design of a prevention trial for Alzheimer’s disease
por: Rafii, Michael S., et al.
Publicado: (2023)

Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study
por: Grober, Ellen, et al.
Publicado: (2022)

Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly
por: Becker, J Alex, et al.
Publicado: (2011)

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
por: Raman, Rema, et al.
Publicado: (2021)

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies
por: Spira, Adam P, et al.
Publicado: (2021)

Nonvascular retinal imaging markers of preclinical Alzheimer's disease
por: Snyder, Peter J., et al.
Publicado: (2016)

Effect of obstructive sleep apnoea on retinal microvascular function: a randomised controlled trial
por: Turnbull, Chris D., et al.
Publicado: (2022)

Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
por: Ngolab, Jennifer, et al.
Publicado: (2019)

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy
por: Yamakiri, Keita, et al.
Publicado: (2008)

A randomised controlled trial evaluating internal limiting membrane peeling forceps in macular hole surgery
por: Ferrara, Mariantonia, et al.
Publicado: (2022)

Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention
por: Insel, Philip S, et al.
Publicado: (2020)

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016)

Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial
por: Hara, Chikako, et al.
Publicado: (2021)

Cognition, Reserve, and Amyloid Deposition in Normal Aging
por: Rentz, Dorene M, et al.
Publicado: (2010)

Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial
por: Hoerauf, Hans, et al.
Publicado: (2011)

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
por: Halawa, Omar A., et al.
Publicado: (2019)

TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology
por: Jimenez-Maggiora, G.A., et al.
Publicado: (2020)

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials
por: Takahashi, Kanji, et al.
Publicado: (2023)

A recommended “minimum data set” framework for SD‐OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)
por: Alber, Jessica, et al.
Publicado: (2020)

Optical coherence tomography angiography–guided vs indocyanine green angiography–guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
por: Li, Siying, et al.
Publicado: (2023)

Amyloid-associated increases in longitudinal report of subjective cognitive complaints
por: Amariglio, Rebecca E., et al.
Publicado: (2018)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

The effect of a preoperative subconjuntival injection of dexamethasone on blood–retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial
por: Bali, Ernesto, et al.
Publicado: (2010)

Amyloid imaging in clinical trials
por: Ossenkoppele, Rik, et al.
Publicado: (2013)

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
por: Harkins, Kristin, et al.
Publicado: (2015)

Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment
por: Kirn, Dylan R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3v7k3psfjr02qpers1c028u3fc